Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:
Enciprazine dihydrochloride
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | Enciprazine dihydrochloride is an orally active non-benzodiazepine anxiolytic agent. It functions as a 5-HT1A receptor (5-HT1AR) agonist and an α1-adrenergic receptor antagonist. This compound induces changes in drug-induced EEG by decreasing the average power of δ and θ waves while increasing the average power of α and fast β waves. Enciprazine dihydrochloride exhibits anti-aggressive activity with only mild sedative and ataxic effects. It modulates plasma corticosterone levels and activates the hypothalamic-pituitary-adrenal axis. Enciprazine dihydrochloride is applicable in studies related to anxiety disorders, generalized anxiety syndrome, and psychotic conditions. |
| In vivo | Enciprazine (oral) dihydrochloride demonstrates anti-aggression and anxiolytic effects in male mice, with an oral ED₅₀ of 1.4 mg/kg observed in the electroshock-induced fighting test. In female rats, a single intraperitoneal dose of Enciprazine (0.3-1.25 mg/kg) slightly increases time spent on open arms in the elevated plus maze, up to 32%, while no activity appears at oral doses of 1.5 to 20 mg/kg in the elevated radial arm maze. Enciprazine (oral) dihydrochloride induces ataxic-sedative effects in mice, with an oral ED₅₀ of 120 mg/kg, having a therapeutic index of 86 compared to its anxiolytic and anti-aggression effects. It enhances barbiturate-induced sedation with an oral ED₅₀ of 46.4 mg/kg in mice, with a therapeutic index of 33 compared to its primary effects. Additionally, it enhances ethanol-induced sedation in mice with an oral ED₅₀ of 45.5 mg/kg, having a therapeutic index of 32.5. Rats exhibit no signs of physical dependence with oral doses up to 2 x 50 mg/kg per day for six days per week over 45 days, as confirmed by the absence of withdrawal symptoms. In male Sprague-Dawley rats, a single intraperitoneal dose of Enciprazine (5 mg/kg) induces statistically significant, time-dependent EEG changes, characterized by reduced δ and θ wave activity and increased α and β₂ wave activity, peaking 30-45 minutes post-injection. |
| Molecular Weight | 505.43 |
| Formula | C23H34Cl2N2O6 |
| Cas No. | 68576-88-5 |
| Smiles | OC(CN1CCN(CC1)C2=C(OC)C=CC=C2)COC3=CC(OC)=C(OC)C(OC)=C3.Cl.Cl |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 µL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.